Literature DB >> 24370897

Current practice patterns for oral chemotherapy: results of a national survey.

Janna C Roop1, Horng-Shiuann Wu1.   

Abstract

PURPOSE/
OBJECTIVES: To describe current nursing practices in the United States regarding care and safety of patients taking oral chemotherapy.
DESIGN: This three-phase study consisted of development, validation, and implementation of a national online survey.
SETTING: Survey of oncology nurses in outpatient settings. SAMPLE: 577 oncology nurses.
METHODS: Surveys were emailed to 5,000 members of the Oncology Nursing Society. The survey included 17 forced-choice items and one free-text item. Descriptive statistics and content analysis were obtained. MAIN RESEARCH VARIABLES: Patient care practices, nursing resources, and barriers to medication adherence.
FINDINGS: Fifty-one percent of the respondents worked in practices that had developed specific policies, procedures, and resources for patients on oral chemotherapy. Barriers to treatment adherence included cost (81%) and adverse effects (72%). Practices with specific policies differed in clinical and statistical significance from practices without policies on almost every survey item. Free-text responses revealed that many practices have erratic procedures and inadequate interdisciplinary communication.
CONCLUSIONS: Systematic reliable policies and procedures for patient education, documentation, and interdisciplinary communication are urgently needed. IMPLICATIONS FOR NURSING: Nurses should provide education and repeated teaching to improve patient safety, adherence to the medication, and self-monitoring for adverse effects.

Entities:  

Keywords:  ambulatory care; chemotherapy; clinical practice; oral chemotherapy; patient education

Mesh:

Substances:

Year:  2014        PMID: 24370897     DOI: 10.1188/14.ONF.41-02AP

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  8 in total

1.  Clinical Outcomes Associated with Drug-Drug Interactions of Oral Chemotherapeutic Agents: A Comprehensive Evidence-Based Literature Review.

Authors:  Manvi Sharma; Aisha Vadhariya; Soumya Chikermane; Suma Gopinathan; Mariana Chavez-MacGregor; Sharon H Giordano; Michael L Johnson; Holly M Holmes
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

Review 2.  Administration of the Tablet Formulation of Olaparib in Patients with Ovarian Cancer: Practical Guidance and Expectations.

Authors:  Kathleen N Moore; Michael J Birrer
Journal:  Oncologist       Date:  2018-03-28

3.  The relationship between patient activation, confidence to self-manage side effects, and adherence to oral oncolytics: a pilot study with Michigan oncology practices.

Authors:  Teresa M Salgado; Emily Mackler; Jane A Severson; Jamie Lindsay; Peter Batra; Laura Petersen; Karen B Farris
Journal:  Support Care Cancer       Date:  2017-01-20       Impact factor: 3.603

Review 4.  Safe handling of oral antineoplastic medications: Focus on targeted therapeutics in the home setting.

Authors:  Yaakov Cass; Thomas H Connor; Alexander Tabachnik
Journal:  J Oncol Pharm Pract       Date:  2016-03-22       Impact factor: 1.809

5.  Inner conflict in patients receiving oral anticancer agents: a qualitative study.

Authors:  Kaori Yagasaki; Hiroko Komatsu; Tsunehiro Takahashi
Journal:  BMJ Open       Date:  2015-04-14       Impact factor: 2.692

6.  Current nursing practice for patients on oral chemotherapy: a multicenter survey in Japan.

Authors:  Hiroko Komatsu; Kaori Yagasaki; Kimio Yoshimura
Journal:  BMC Res Notes       Date:  2014-04-23

7.  Medication Experience and Adherence to Oral Chemotherapy: A Qualitative Study of Patients' and Health Professionals' Perspectives.

Authors:  Amparo Talens; Mercedes Guilabert; Blanca Lumbreras; María Teresa Aznar; Elsa López-Pintor
Journal:  Int J Environ Res Public Health       Date:  2021-04-17       Impact factor: 3.390

8.  Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists.

Authors:  Lonneke Timmers; Christel C L M Boons; Mathieu Verbrugghe; Bart J F van den Bemt; Ann Van Hecke; Jacqueline G Hugtenburg
Journal:  BMC Cancer       Date:  2017-02-10       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.